Famotidine Trial In The US: Government Health Officials Raise Serious Concerns About Patient Safety And Scientific Integrity Of The Study
Only two months ago, the Trump administration, awarded $21 million to study whether a common heartburn drug was effective against COVID-19. Now a new agency which claims to have accessed…
Share